Cargando…
Identification of MFGE8 in mesenchymal stem cell secretome as an anti-fibrotic factor in liver fibrosis
The beneficial paracrine roles of mesenchymal stem cells (MSCs) in tissue repair have potential in therapeutic strategies against various diseases. However, the key therapeutic factors secreted from MSCs and their exact molecular mechanisms of action remain unclear. In this study, the cell-free secr...
Autores principales: | Jang, Yu Jin, An, Su Yeon, Kim, Jong-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342867/ https://www.ncbi.nlm.nih.gov/pubmed/28115038 http://dx.doi.org/10.5483/BMBRep.2017.50.2.012 |
Ejemplares similares
-
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
por: Yao, Xia, et al.
Publicado: (2020) -
Mesenchymal stem cells secretome: current trends and future challenges
por: Teixeira, Fábio G., et al.
Publicado: (2019) -
MFGE8 is down‐regulated in cardiac fibrosis and attenuates endothelial‐mesenchymal transition through Smad2/3‐Snail signalling pathway
por: Wang, Bo, et al.
Publicado: (2020) -
Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
por: Nazarie (Ignat), Simona-Rebeca, et al.
Publicado: (2021) -
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?
por: Bari, Elia, et al.
Publicado: (2021)